Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

90 trials

NCT06885697
Recruiting
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Phase 1 · United States · 1 site
Registry update: 5 Nov 2026
NCT06840834
Recruiting
Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy
Phase 2 · France · 21 sites
Registry update: 10 Aug 2026
Conflicting statuses (not updated in the registry for 3 months)
NCT06710756
Recruiting
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Phase 1/2 · United States · 16 sites
Registry update: 28 Oct 2026
NCT06875076
Recruiting
Multicenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural Mesothelioma
Phase 2 · China · 1 site
Registry update: 13 Mar 2025
NCT06790082
Recruiting
The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma
Phase 2 · Denmark · 1 site
Registry update: 2 Nov 2026
NCT07072143
Recruiting
An International Study on Pediatric Patients With Rare Tumors.
Not applicable · Italy · 1 site
Registry update: 18 Jul 2025
NCT06566079
Recruiting
Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
Phase 1/2 · China, United States · 10 sites
Registry update: 16 Sept 2026
2024-519286-21-00
Recruiting
PHASE III STUDY WITH ATEZOLIZUMAB VERSUS PLACEBO IN MALIGNANT PLEURAL MESOTHELIOMA PATIENTS AFTER PLEURECTOMY/DECORTICATION
Phase 3 · Italy · 14 sites
Registry update: 4 Nov 2026
NCT05647265
Recruiting
Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma
Phase 2 · United States · 132 sites
Registry update: 5 Aug 2026
NCT06623396
Recruiting
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer or Malignant Peritoneal Mesothelioma
Phase 1 · United States · 7 sites
Registry update: 15 Oct 2026
NCT06444815
Recruiting
A Study of VET3-TGI in Patients With Solid Tumors
Phase 1 · United States · 7 sites
Registry update: 7 Apr 2026
NCT05188859
Recruiting
First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma
Phase 2 · China · 2 sites
Registry update: 31 May 2025
NCT07561190
Recruiting
Multidimensional Omics Analysis in Malignant Pleural Mesothelioma
Not applicable · Italy · 4 sites
Registry update: 1 May 2026
NCT06362369
Recruiting
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Phase 1/2 · United States · 5 sites
Registry update: 13 Apr 2026
NCT06535607
Recruiting
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
Phase 2 · Australia, Brazil, Canada, China, Germany, United Kingdom, Italy, Japan, South Korea, Taiwan, United States, Vietnam · 70 sites
Registry update: 11 Sept 2026
NCT06251310
Recruiting
SW-682 in Advanced Solid Tumors
Phase 1 · United States · 8 sites
Registry update: 30 Oct 2026
NCT06536179
Recruiting
New Preclinical and Clinical Approaches to Mesothelioma
Not applicable · Italy · 2 sites
Registry update: 2 Aug 2024
NCT05932199
Recruiting
Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
Phase 1/2 · United States · 2 sites
Registry update: 2 Oct 2026
NCT06452160
Recruiting
A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors
Phase 1 · United States · 1 site
Registry update: 9 Aug 2024
NCT06477419
Recruiting
A Study of Sacituzumab Govitecan in People With Mesothelioma
Phase 2 · United States · 7 sites
Registry update: 28 May 2026

Ordered by registry start date. Freshness and sponsorship never change the order.